Berkeley Lights Inc.
| NASDAQ: BLI |
| Healthcare / Biotechnology / USA |
| 5.40 | -0.3700 | -6.41% | Vol 647.68K | 1Y Perf -88.00% |
| Jun 27th, 2022 16:00 DELAYED |
| BID | 5.21 | ASK | 5.95 | ||
| Open | 5.77 | Previous Close | 5.77 | ||
| Pre-Market | - | After-Market | 5.40 | ||
| - - | - -% |
| Target Price | 18.50 | Analyst Rating | Moderate Buy 2.00 | |
| Potential % | 242.59 | Finscreener Ranking | — - | |
| Insiders Trans % 3/6/12 mo. | -/-/- | Value Ranking | ★★+ 49.26 | |
| Insiders Value % 3/6/12 mo. | -/-/- | Growth Ranking | ★★★ 51.33 | |
| Insiders Shares Cnt. % 3/6/12 mo. | -/-/- | Income Ranking | — - | |
| Price Range Ratio 52W % | 3.66 | Earnings Rating | — | |
| Market Cap | 366.26M | Earnings Date | 10th Aug 2022 | |
| Alpha | -0.12 | Standard Deviation | 0.18 | |
| Beta | 2.40 |
Today's Price Range 5.345.78 | 52W Range 3.6651.28 |
Summary:
Buy
| Technical Indicators: | Buy |
| Moving Averages: | Buy |
| Performance | |||
|---|---|---|---|
| 1 Week | 22.77% | ||
| 1 Month | 28.22% | ||
| 3 Months | -14.77% | ||
| 6 Months | -69.77% | ||
| 1 Year | -88.00% | ||
| 3 Years | - | ||
| 5 Years | - | ||
| 10 Years | - |
| Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
ROE (5Y Avg) | - | |||
ROE last 12 Months | -36.83 | |||
ROA (5Y Avg) | - | |||
ROA last 12 Months | -28.16 | |||
ROC (5Y Avg) | - | |||
ROC last 12 Months | -29.59 | |||
Return on invested Capital Q | -8.61 | |||
Return on invested Capital Y | -27.14 | |||
Assets Turnover | 0.30 | |||
Receivables Turnover | 5.20 |
| Valuation | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| -4.10 | ||||
| 1.65 | ||||
| 3.67 | ||||
| - | ||||
| -4.50 | ||||
| -0.77 | ||||
| 1.65 | ||||
| 2.85 | ||||
| 200.44M | ||||
| Forward PE | - | |||
| PEG | - |
| Financial Strength | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 6.70 | ||||
| 7.50 | ||||
| 0.18 | ||||
| 0.24 | ||||
| -73.70 | ||||
| Leverage Ratio | 1.30 |
| Profitability | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 66.60 | ||||
| -88.20 | ||||
| -78.10 | ||||
| - | ||||
| -89.42 |
| Revenue | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 86.97M | ||||
| 1.28 | ||||
| 16.85 | ||||
| - |
| Dividends | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| - | ||||
| - | ||||
| - | ||||
| - | ||||
| Payout ratio | - |
| Earnings History | Estimate | Reported | Surprise % |
|---|---|---|---|
| Q01 2022 | -0.31 | -0.32 | -3.23 |
| Q04 2021 | -0.25 | -0.26 | -4.00 |
| Q03 2021 | -0.23 | -0.30 | -30.43 |
| Q02 2021 | -0.24 | -0.27 | -12.50 |
| Q01 2021 | -0.23 | -0.24 | -4.35 |
| Q04 2020 | -0.20 | -0.19 | 5.00 |
| Q03 2020 | -0.20 | -0.16 | 20.00 |
| Q02 2020 | -1.06 | -4.25 | -300.94 |
| Earnings Per End | Estimate | Revision % | Trend |
|---|---|---|---|
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| Next Report Date | 10th Aug 2022 |
| Estimated EPS Next Report | -0.30 |
| Estimates Count | 5 |
| EPS Growth Next 5 Years % | - |
| Volume Overview | |
|---|---|
| Volume | 647.68K |
| Shares Outstanding | 67.83K |
| Shares Float | 50.10M |
| Trades Count | 8.43K |
| Dollar Volume | 3.58M |
| Avg. Volume | 1.17M |
| Avg. Weekly Volume | 1.48M |
| Avg. Monthly Volume | 1.03M |
| Avg. Quarterly Volume | 988.82K |
Berkeley Lights Inc. (NASDAQ: BLI) stock closed at 5.77 per share at the end of the most recent trading day (a -1.2% change compared to the prior day closing price) with a volume of 2.14M shares and market capitalization of 366.26M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 210 people. Berkeley Lights Inc. CEO is Eric D. Hobbs.
The one-year performance of Berkeley Lights Inc. stock is -88%, while year-to-date (YTD) performance is -68.26%. BLI stock has a five-year performance of %. Its 52-week range is between 3.655 and 51.2825, which gives BLI stock a 52-week price range ratio of 3.66%
Berkeley Lights Inc. currently has a PE ratio of -4.10, a price-to-book (PB) ratio of 1.65, a price-to-sale (PS) ratio of 3.67, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -28.16%, a ROC of -29.59% and a ROE of -36.83%. The company’s profit margin is -89.42%, its EBITDA margin is -78.10%, and its revenue ttm is $86.97 Million , which makes it $1.28 revenue per share.
Of the last four earnings reports from Berkeley Lights Inc., there were 0 positive earnings surprise and 4 negative earnings surprise. The company has EPS estimate of $-0.30 for the next earnings report. Berkeley Lights Inc.’s next earnings report date is 10th Aug 2022.
The consensus rating of Wall Street analysts for Berkeley Lights Inc. is Moderate Buy (2), with a target price of $18.5, which is +242.59% compared to the current price. The earnings rating for Berkeley Lights Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Berkeley Lights Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Berkeley Lights Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 28.23, ATR14 : 0.54, CCI20 : 174.03, Chaikin Money Flow : 0.15, MACD : 0.09, Money Flow Index : 75.04, ROC : 8.87, RSI : 59.12, STOCH (14,3) : 84.66, STOCH RSI : 0.94, UO : 62.04, Williams %R : -15.34), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Berkeley Lights Inc. in the last 12-months were:
Berkeley Lights Inc.
Berkeley Lights Inc is a digital cell biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The Berkeley Lights platform captures deep phenotypic, functional and genotypic information for thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. The Berkeley Lights Platform is a fully integrated, end-to-end solution, comprised of proprietary consumables, including its OptoSelect chips and reagent kits, advanced automation systems and advanced application and workflow software. The company operates in North America, Asia Pacific and Europe, with North America deriving majority of the revenue.
CEO: Eric D. Hobbs
Telephone: +1 510 858-2855
Address: 5858 Horton Street, Emeryville 94608, CA, US
Number of employees: 210
